BG108459A - Antitumoral formulations of thioxanthenone - Google Patents
Antitumoral formulations of thioxanthenoneInfo
- Publication number
- BG108459A BG108459A BG108459A BG10845903A BG108459A BG 108459 A BG108459 A BG 108459A BG 108459 A BG108459 A BG 108459A BG 10845903 A BG10845903 A BG 10845903A BG 108459 A BG108459 A BG 108459A
- Authority
- BG
- Bulgaria
- Prior art keywords
- thioxanthenone
- antitumoral
- formulations
- oxothioxanthen
- diethylamino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0115893.0A GB0115893D0 (en) | 2001-06-28 | 2001-06-28 | Formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
BG108459A true BG108459A (en) | 2005-02-28 |
Family
ID=9917582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG108459A BG108459A (en) | 2001-06-28 | 2003-12-16 | Antitumoral formulations of thioxanthenone |
Country Status (22)
Country | Link |
---|---|
US (1) | US20050176619A1 (es) |
EP (1) | EP1406699A1 (es) |
JP (1) | JP2004536099A (es) |
KR (1) | KR20040030709A (es) |
CN (1) | CN1520325A (es) |
AR (1) | AR034621A1 (es) |
BG (1) | BG108459A (es) |
BR (1) | BR0210671A (es) |
CA (1) | CA2451195A1 (es) |
CZ (1) | CZ20033434A3 (es) |
EE (1) | EE200400041A (es) |
GB (1) | GB0115893D0 (es) |
HR (1) | HRP20031048A2 (es) |
HU (1) | HUP0402039A2 (es) |
IL (1) | IL159206A0 (es) |
IS (1) | IS7070A (es) |
MX (1) | MXPA03012064A (es) |
NO (1) | NO20035668D0 (es) |
PL (1) | PL367636A1 (es) |
RU (1) | RU2003136086A (es) |
SK (1) | SK15492003A3 (es) |
WO (1) | WO2003002202A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006213662B2 (en) * | 2005-02-11 | 2010-08-05 | Immunogen, Inc. | Process for preparing stable drug conjugates |
CA2892010A1 (en) * | 2012-11-20 | 2014-05-30 | Vita Naturale, Llc | Compositions and methods for their dermatological use |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5346917A (en) * | 1991-06-10 | 1994-09-13 | Sterling Winthrop Inc. | Thioxanthenone antitumor agents |
US5665760A (en) * | 1995-09-18 | 1997-09-09 | Sanofi Winthrop, Inc. | Lyophilized thioxanthenone antitumor agents |
US20030022920A1 (en) * | 2001-06-19 | 2003-01-30 | Christoph Ullmer | 1-Methyl-4- (3-ethoxy-9H-thioxanthene-9-ylidene) -piperidine and its use as 5-HT2B/H1 receptor antagonist |
-
2001
- 2001-06-28 GB GBGB0115893.0A patent/GB0115893D0/en not_active Ceased
-
2002
- 2002-06-24 AR ARP020102369A patent/AR034621A1/es not_active Application Discontinuation
- 2002-06-28 WO PCT/GB2002/003012 patent/WO2003002202A1/en not_active Application Discontinuation
- 2002-06-28 EP EP02748985A patent/EP1406699A1/en not_active Withdrawn
- 2002-06-28 IL IL15920602A patent/IL159206A0/xx unknown
- 2002-06-28 KR KR10-2003-7016976A patent/KR20040030709A/ko not_active Application Discontinuation
- 2002-06-28 CN CNA028127552A patent/CN1520325A/zh active Pending
- 2002-06-28 RU RU2003136086/15A patent/RU2003136086A/ru not_active Application Discontinuation
- 2002-06-28 HU HU0402039A patent/HUP0402039A2/hu unknown
- 2002-06-28 CA CA002451195A patent/CA2451195A1/en not_active Abandoned
- 2002-06-28 EE EEP200400041A patent/EE200400041A/xx unknown
- 2002-06-28 PL PL02367636A patent/PL367636A1/xx not_active Application Discontinuation
- 2002-06-28 MX MXPA03012064A patent/MXPA03012064A/es not_active Application Discontinuation
- 2002-06-28 US US10/480,692 patent/US20050176619A1/en not_active Abandoned
- 2002-06-28 BR BR0210671-0A patent/BR0210671A/pt not_active IP Right Cessation
- 2002-06-28 CZ CZ20033434A patent/CZ20033434A3/cs unknown
- 2002-06-28 SK SK1549-2003A patent/SK15492003A3/sk unknown
- 2002-06-28 JP JP2003508438A patent/JP2004536099A/ja active Pending
-
2003
- 2003-12-11 IS IS7070A patent/IS7070A/is unknown
- 2003-12-16 BG BG108459A patent/BG108459A/xx unknown
- 2003-12-17 HR HR20031048A patent/HRP20031048A2/xx not_active Application Discontinuation
- 2003-12-18 NO NO20035668A patent/NO20035668D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EE200400041A (et) | 2004-04-15 |
IS7070A (is) | 2003-12-11 |
SK15492003A3 (sk) | 2004-06-08 |
CZ20033434A3 (cs) | 2004-08-18 |
US20050176619A1 (en) | 2005-08-11 |
HRP20031048A2 (en) | 2004-04-30 |
KR20040030709A (ko) | 2004-04-09 |
IL159206A0 (en) | 2004-06-01 |
JP2004536099A (ja) | 2004-12-02 |
CN1520325A (zh) | 2004-08-11 |
RU2003136086A (ru) | 2005-05-27 |
EP1406699A1 (en) | 2004-04-14 |
MXPA03012064A (es) | 2004-03-26 |
AR034621A1 (es) | 2004-03-03 |
HUP0402039A2 (hu) | 2005-01-28 |
NO20035668D0 (no) | 2003-12-18 |
WO2003002202A1 (en) | 2003-01-09 |
GB0115893D0 (en) | 2001-08-22 |
CA2451195A1 (en) | 2003-01-09 |
BR0210671A (pt) | 2004-10-13 |
PL367636A1 (en) | 2005-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL144294A0 (en) | P53 inhibitors and therapeutic use of the same | |
IL220096A0 (en) | Use of 40-o-(2-hydroxyethyl)- rapamycin in the prepartion of pharmaceutical compsoitons for the treatment of solid tumors | |
SI1458360T1 (sl) | Pulmonalno dajanje aminoglikozidov | |
HUP0401461A3 (en) | Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use | |
HRP20010738B1 (en) | N-cyanomethyl amides as protease inhibitors | |
HK1080459A1 (en) | Novel pyrimidineamide derivatives and the use thereof | |
IL160755A (en) | N - (2 - bromophenyl) - n' [((r) - 1 - (5 - trifluoromethyl - 2 - pyridyl) pyrrolidin - 3 - yl)] urea, pharmaceutical compositions comprising it and process for its preparation | |
GB2352395A (en) | Paroxetine methanesulfonate | |
IL202332A0 (en) | Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer | |
IL153708A0 (en) | Benzimidazole derivatives, preparation and therapeutic use thereof | |
PL398391A1 (pl) | Koniugat hydroksyalkiloskrobi i polipeptydu, sposób wytwarzania tego koniugatu, jego zastosowanie oraz kompozycja farmaceutyczna zawierająca koniugat hydroksyalkiloskrobi i polipeptydu | |
MY128362A (en) | Spontaneously dispersible n-benzoyl staurosporine compositions | |
AU5338401A (en) | Methods and compositions for modulating alpha adrenergic receptor activity | |
TW200633694A (en) | Composition and method for treating asthma | |
WO2001068645A3 (en) | N-cyanomethylcarboxamides and their use as protease inhibitors | |
TWI318974B (en) | Acylaminothiazole derivatives, their preparation and their therapeutic use | |
ZA200208761B (en) | Pharmaceutical form of administration for peptides, methods for its production and use. | |
MXPA03012064A (es) | Formulaciones antitumorales de tioxantenona. | |
IL156647A0 (en) | 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof | |
MY130445A (en) | Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone | |
MY136976A (en) | Novel use of (r)-(-)-2-[5-(4- flourophenyl) -3-pyridylmethylaminomethyl]- chromane and its physiologically acceptable salts | |
HUP0203181A3 (en) | Peptides for treatment of erectile dysfunction, pharmaceutical compositions and their use | |
HK1065792A1 (en) | 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino Ä4,5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use | |
AU2003285125A8 (en) | Polymer compositions comprising antifibrotic agents, and methods of treatment, pharmaceutical compositions, and methods of preparation therefor | |
AU2001291256A1 (en) | Methods and compositions for the identification, assessment and therapy of human cancers |